Novartis, Roxane Drop Most Famvir Patent Claims

By Hilary Russ

Law360, New York (January 06, 2010, 2:58 PM ET) -- A federal judge has approved a joint move by Novartis Pharmaceuticals Corp. and Roxane Laboratories Inc. to dismiss claims regarding three of four patents in the drugmakers' battle over Novartis herpes treatment Famvir.

Judge Jose L. Linares of the U.S. District Court for the District of New Jersey on Tuesday signed off on the consent order for the joint stipulation of dismissal with prejudice by the companies, which agreed to drop claims and counterclaims against each other in the consolidated case, but left alive claims concerning...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles